STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 21,960	$ 19,516
General and administrative	7,030	6,162
Total operating expenses	28,990	25,678
Loss from operations	(28,990)	(25,678)
Other income, net	3,979	1,733
Net loss	(25,011)	(23,945)
Other comprehensive income (loss):
Unrealized gain or loss on investments	(420)	792
Comprehensive loss	$ (25,431)	$ (23,153)
Net loss per share, basic	$ (0.37)	$ (0.53)
Net loss per share, diluted	$ (0.37)	$ (0.53)
Weighted-average shares outstanding, basic	67,349,551	45,090,166
Weighted-average shares outstanding, diluted	67,349,551	45,090,166